98 related articles for article (PubMed ID: 8401226)
1. A study of the effects of altering the sites for N-glycosylation in alpha-1-proteinase inhibitor variants M and S.
Samandari T; Brown JL
Protein Sci; 1993 Sep; 2(9):1400-10. PubMed ID: 8401226
[TBL] [Abstract][Full Text] [Related]
2. Effects of mutations that alter the Glu264-Lys387 salt bridge on the secretion of alpha-1-proteinase inhibitor.
Brodbeck RM; Samandari T; Brown JL
J Biol Chem; 1993 Mar; 268(9):6771-6. PubMed ID: 8454649
[TBL] [Abstract][Full Text] [Related]
3. Construction and expression of alpha 1-proteinase inhibitor mutants and the effects of these mutations on secretion of the variant inhibitors.
McCracken AA; Kruse KB; Valentine J; Roberts C; Yohannes TZ; Brown JL
J Biol Chem; 1991 Apr; 266(12):7578-82. PubMed ID: 2019587
[TBL] [Abstract][Full Text] [Related]
4. Intracellular retention and degradation of human mutant variant of a alpha 1-antitrypsin in stably transfected Chinese hamster ovary cell lines.
Ciccarelli E; Alonso MA; Cresteil D; Bollen A; Jacobs P; Alvarez F
Eur J Biochem; 1993 Apr; 213(1):271-6. PubMed ID: 8477700
[TBL] [Abstract][Full Text] [Related]
5. Structural studies of alpha-N-acetylgalactosaminidase: effect of glycosylation on the level of expression, secretion efficiency, and enzyme activity.
Zhu A; Wang ZK; Beavis R
Arch Biochem Biophys; 1998 Apr; 352(1):1-8. PubMed ID: 9521804
[TBL] [Abstract][Full Text] [Related]
6. Structural characterization of recombinant alpha-1-antitrypsin expressed in a human cell line.
Wang Z; Hilder TL; van der Drift K; Sloan J; Wee K
Anal Biochem; 2013 Jun; 437(1):20-8. PubMed ID: 23462539
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis for defective secretion of the Z variant of human alpha-1-proteinase inhibitor: secretion of variants having altered potential for salt bridge formation between amino acids 290 and 342.
McCracken AA; Kruse KB; Brown JL
Mol Cell Biol; 1989 Apr; 9(4):1406-14. PubMed ID: 2786139
[TBL] [Abstract][Full Text] [Related]
8. Mutagenesis of N-glycosylation sites in the human vasoactive intestinal peptide 1 receptor. Evidence that asparagine 58 or 69 is crucial for correct delivery of the receptor to plasma membrane.
Couvineau A; Fabre C; Gaudin P; Maoret JJ; Laburthe M
Biochemistry; 1996 Feb; 35(6):1745-52. PubMed ID: 8639654
[TBL] [Abstract][Full Text] [Related]
9. Secretion of alpha-1-proteinase inhibitor requires an almost full length molecule.
Brodbeck RM; Brown JL
J Biol Chem; 1992 Jan; 267(1):294-7. PubMed ID: 1730596
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the properties of rare variants of alpha1-proteinase inhibitor expressed in COS-1 cells and assessment of their potential as risk factors in human disease.
Ray S; Mickleborough TD; Brown JL
Biochim Biophys Acta; 2005 Jun; 1740(3):390-402. PubMed ID: 15949707
[TBL] [Abstract][Full Text] [Related]
11. Serum alpha 1-antitrypsin deficiency associated with the common S-type (Glu264----Val) mutation results from intracellular degradation of alpha 1-antitrypsin prior to secretion.
Curiel DT; Chytil A; Courtney M; Crystal RG
J Biol Chem; 1989 Jun; 264(18):10477-86. PubMed ID: 2567291
[TBL] [Abstract][Full Text] [Related]
12. Site-directed mutagenesis of glycosylation sites in the transforming growth factor-beta 1 (TGF beta 1) and TGF beta 2 (414) precursors and of cysteine residues within mature TGF beta 1: effects on secretion and bioactivity.
Brunner AM; Lioubin MN; Marquardt H; Malacko AR; Wang WC; Shapiro RA; Neubauer M; Cook J; Madisen L; Purchio AF
Mol Endocrinol; 1992 Oct; 6(10):1691-700. PubMed ID: 1448117
[TBL] [Abstract][Full Text] [Related]
13. Mutations of rat surfactant protein A have distinct effects on its glycosylation, secretion, aggregation and degradation.
Yang W; Shen H; Fang G; Li H; Li L; Deng F; Gu W; Li K; Ma L; Gu J; Wang Y
Life Sci; 2014 Nov; 117(2):47-55. PubMed ID: 25242514
[TBL] [Abstract][Full Text] [Related]
14. The role of asparagine-linked oligosaccharides in the subunit structure, steroid binding, and secretion of androgen-binding protein.
Joseph DR; Lawrence W; Danzo BJ
Mol Endocrinol; 1992 Jul; 6(7):1127-34. PubMed ID: 1508225
[TBL] [Abstract][Full Text] [Related]
15. Comparative properties of human alpha-1-proteinase inhibitor glycosylation variants.
Guzdek A; Potempa J; Dubin A; Travis J
FEBS Lett; 1990 Oct; 272(1-2):125-7. PubMed ID: 2146158
[TBL] [Abstract][Full Text] [Related]
16. Role of N-linked oligosaccharide chains in the processing and antigenicity of measles virus haemagglutinin protein.
Hu A; Cattaneo R; Schwartz S; Norrby E
J Gen Virol; 1994 May; 75 ( Pt 5)():1043-52. PubMed ID: 8176366
[TBL] [Abstract][Full Text] [Related]
17. Non-lysosomal degradation of misfolded human lysozymes with and without an asparagine-linked glycosylation site.
Omura F; Otsu M; Yoshimori T; Tashiro Y; Kikuchi M
Eur J Biochem; 1992 Dec; 210(2):591-9. PubMed ID: 1459141
[TBL] [Abstract][Full Text] [Related]
18. Transmembrane folding of the human erythrocyte anion exchanger (AE1, Band 3) determined by scanning and insertional N-glycosylation mutagenesis.
Popov M; Li J; Reithmeier RA
Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):269-79. PubMed ID: 10191257
[TBL] [Abstract][Full Text] [Related]
19. Role of N-linked glycosylation on the function and expression of the human secretin receptor.
Pang RT; Ng SS; Cheng CH; Holtmann MH; Miller LJ; Chow BK
Endocrinology; 1999 Nov; 140(11):5102-11. PubMed ID: 10537138
[TBL] [Abstract][Full Text] [Related]
20. Role of individual N-linked glycosylation sites in the function and intracellular transport of the human alpha folate receptor.
Roberts SJ; Petropavlovskaja M; Chung KN; Knight CB; Elwood PC
Arch Biochem Biophys; 1998 Mar; 351(2):227-35. PubMed ID: 9515058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
